The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases

European Journal of Human Genetics

Volumn 23, Issue 9, 2015, Pages 1116-1123

  Mora, Marina ^a   Angelini, Corrado ^b,c   Bignami, Fabrizia ^d   Bodin, Anne Mary ^e   Crimi, Marco ^f   Di Donato, Jeanne Hélène ^g   Felice, Alex ^h   Jaeger, Cécile ⁱ   Karcagi, Veronika ^j   Lecam, Yann ^e   Lynn, Stephen ^k   Meznaric, Marija ^l   Moggio, Maurizio ^m   Monaco, Lucia ^f   Politano, Luisa ⁿ   De La Paz, Manuel Posada ^o   Saker, Safaa ^p   Schneiderat, Peter ^q   Ensini, Monica ^k   Garavaglia, Barbara ^a   Gurwitz, David ^r   Johnson, Diana ^s   Muntoni, Francesco ^s   Puymirat, Jack ^t   Reza, Mojgan ^t   Voit, Thomas ^u   Baldo, Chiara ^v   Bricarelli, Franca Dagna ^v   Goldwurm, Stefano ^w   Merla, Giuseppe ^x   Pegoraro, Elena ^c   Renieri, Alessandra ^y   Zatloukal, Kurt ^z   Filocamo, Mirella ^aa   Lochmüller, Hanns ^k   more..

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b IRCCS Fondazione San Camillo Hospital   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Plateforme Maladies Rares   (France)

^f FONDAZIONE TELETHON   (Italy)

^g UMR EHESS CNRS 8562 Norbert Elias   (France)

^h UNIVERSITY OF MALTA   (Malta)

ⁱ FOCH HOSPITAL   (France)

^j NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH   (Hungary)

^k NEWCASTLE UNIVERSITY   (United Kingdom)

^l UNIVERSITY OF LJUBLJANA   (Slovenia)

^m UNIVERSITY OF MILAN   (Italy)

ⁿ SECOND UNIVERSITY OF NAPLES   (Italy)

^o INSTITUTO DE SALUD CARLOS III   (Spain)

^p GÉNÉTHON   (France)

^q LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^r TEL AVIV UNIVERSITY   (Israel)

^s UNIVERSITY COLLEGE LONDON   (United Kingdom)

^t LAVAL UNIVERSITY   (Canada)

^u Sorbonne Université   (France)

^v GALLIERA HOSPITAL   (Italy)

^w PARKINSON INSTITUTE   (Italy)

^x CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^y UNIVERSITY OF SIENA   (Italy)

^z MEDICAL UNIVERSITY OF GRAZ   (Austria)

^aa G GASLINI INSTITUTE   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACHIEVEMENT; ARTICLE; BIOBANKING; BIOINFORMATICS; CONCEPTUAL FRAMEWORK; DECISION MAKING; DISEASE REGISTRY; EUROBIOBANK NETWORK; EUROPEAN; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HUMAN; INFORMATION PROCESSING; INFORMATION TECHNOLOGY; INTERNATIONAL COOPERATION; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUBLICATION; QUALITY CONTROL; RARE DISEASE; TOTAL QUALITY MANAGEMENT; BIOBANK; BIOLOGY; EUROPE; GENETICS; ORGANIZATION AND MANAGEMENT; PATHOLOGY; RARE DISEASES; REGISTER;

BIOLOGICAL SPECIMEN BANKS; COMPUTATIONAL BIOLOGY; EUROPE; HUMANS; INTERNATIONAL COOPERATION; QUALITY CONTROL; RARE DISEASES; REGISTRIES;

EID: 84939265617     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.272     Document Type: Article

References (51)

1. OECD: Glossary of Statistical Terms, 2006. Available at http://stats.oecd.org/glossary/ detail.asp?ID=7220.
2. Filocamo M, Baldo C, Goldwurm S et al: Telethon Network of Genetic Biobanks: a key service for diagnosis and research on rare diseases. Orphanet J Rare Dis 2013; 8: 129.
3. Asslaber M, Zatloukal K: Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic 2007; 6: 193-201.
4. Yuille M, van Ommen GJ, Bréchot C et al: Biobanking for Europe. Brief Bioinform 2008; 9: 14-24.
5. Harris JR, Burton P, Knoppers BM et al: Toward a roadmap in global biobanking for health. Eur J Hum Genet 2012; 20: 1105-1111.
6. Lochmüller H, Aymé S, Pampinella F: The role of biobanking in rare diseases: European consensus expert group report. Biopreserv Biobank 2009; 7: 155-156.
7. Lochmüller H, Schneiderat P: Biobanking in rare disorders. Adv ExpMed Biol 2010; 686: 105-113.
8. OECD: Guidance for the Operation of Biological Research Centres (BRCs), 2004, Available at http://www.oecd.org/dataoecd/60/44/23547773.pdf.
9. Uranga AM, Martin-Arribas MC, Di Donato JH et al: Outstanding Legal and Ethical Issues on BioBanks-An Overview on the regulations of member states of the EuroBioBank project, 2005. Available at http://www.eurobiobank.org/en/intranet/workflow/ uploadDir/PDFmarcadoresEUROBIOBANK-ING.pdf.
10. Palmieri L, Alberio S, Pisano I et al: Complete loss-of-function of the heart/musclespecific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum Mol Genet 2005; 14: 3079-3088.
11. Mayr JA, Merkel O, Kohlwein SD et al: Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 2007; 80: 478-484.
12. Borg J, Papadopoulos P, Georgitsi M et al: Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 2010; 42: 733-734.
13. Behar DM, Yunusbayev B, Metspalu M et al: The genome-wide structure of the Jewish people. Nature 2010; 466: 238-242.
14. Piluso G, Dionisi M, Del Vecchio Blanco F et al: Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders. Clin Chem 2011; 57: 1584-1596.
15. Kemp JP, Smith PM, Pyle A et al: Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain 2011; 134: 183-195.
16. Senderek J, Müller JS, Dusl M et al: Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect. Am J Hum Genet 2011; 88: 162-172.
17. Manzini C, Tambunan DE, Hill RS et al: Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause for Walker-Warburg Syndrome. Am J Hum Genet 2012; 91: 541-547.
18. Bello L, Piva L, Barp A et al: Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy. Neurology 2012; 79: 159-162.
19. Cozzi A, Santambrogio P, Privitera D et al: Human L-ferritin deficiency is characterized by idiopathic generalized seizures and atypical restless leg syndrome. J Exp Med 2013; 210: 1779-1791.
20. Dusi S, Valletta L, Haack TB et al: Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation. Am J Hum Genet 2014; 94: 11-22.
21. Micale L, Augello B, Maffeo C et al: Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of kabuki syndrome patients. Hum Mutat 2014; 35: 841-850.
22. Di Costanzo S, Balasubramanian A, Pond HL et al: POMK mutations disrupt muscle development leading to a spectrum of neuromuscular presentations. Hum Mol Genet 2014; 23: 5781-5792.
23. Krause S, Hinderlich S, Amsili S et al: Localization of UDP-GlcNAc 2-epimerase/ManAc kinase (GNE) in the Golgi complex and the nucleus of mammalian cells. Exp Cell Res 2005; 304: 365-379.
24. Thirion C, Lochmüller H, Ruzsics Z: Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy. Hum Gene Ther 2006; 17: 193-205.
25. Janiesch PC, Kim J, Mouysset J et al: The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat Cell Biol 2007; 9: 379-390.
26. Bulst S, Abicht A, Holinski-Feder E et al: In vitro supplementation with dAMP/dGMP leads to partial restoration of mtDNA levels in mitochondrial depletion syndromes. Hum Mol Genet 2009; 18: 1590-1599.
27. Zanotti S, Gibertini S, Mora M: Muscle-derived Duchenne muscular dystrophy fibroblasts show altered production of extracellular matrix components. Cell Tissue Res 2010; 339: 397-410.
28. Colombo E, Romaggi S, Medico E et al: The human neurotrophin receptor p75NTR defines differentiation-oriented skeletal muscle precursor cells: implications for muscle regeneration. J Neuropathol Exp Neurol 2011; 70: 133-142.
29. Dick E, Matsa E, Bispham J et al: Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines. Stem Cell Res 2011; 6: 158-167.
30. Campanella A, Privitera D, Guaraldo M et al: Skin fibroblasts from pantothenate kinase-associate neurodegeneration patients show altered cellular oxidative status and have defective iron-handling properties. Hum Mol Genet 2012; 21: 4049-4059.
31. Tedesco FS, Gerli MF, Perani L et al: Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 2012; 4: 140ra89.
32. Spendiff S, Reza M, Murphy JL et al: Mitochondrial DNA deletions in muscle satellite cells: implications for therapies. Hum Mol Genet 2013; 22: 4739-4747.
33. Stevens E, Torelli S, Feng L et al: Flow cytometry for the analysis of dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies. PLoS One 2013; 8: e68958.
34. Livide G, Patriarchi T, Amenduni M et al: GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. Eur J Hum Genet 2015; 23: 195-201.
35. Gabellini D, D'Antona G, Moggio M et al: Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006; 439: 973-977.
36. Eisenberg I, Eran A, Nishino I et al: Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci USA 2007; 104: 17016-17021.
37. Guglieri M, Magri F, D'Angelo MG et al: Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008; 29: 258-266.
38. Meznaric M, Gonzalez-Quereda L, Gallardo E et al: Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele. Eur J Neurol 2011; 18: 1021-1023.
39. Mutsaers CA, Wishart TM, Lamont DJ et al: Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet 2011; 20: 4334-4344.
40. Angelini C, Semplicini C: Enzyme replacement therapy for Pompe disease. Curr Neurol Neurosci Rep 2012; 12: 70-75.
41. Gidaro T, Negroni E, Perié S et al: Atrophy, fibrosis, and increased PAX7-positive cells in pharyngeal muscles of oculopharyngeal muscular dystrophy patients. J Neuropathol Exp Neurol 2013; 72: 234-243.
42. Kalko SG, Paco S, Jou C et al: Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 2014; 15: 91.
43. Ayoglu B, Chaouch A, Lochmüller H et al: Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies. EMBO Mol Med 2014; 6: 918-936.
44. Mabile L, Dalgleish R, Thorisson GA et al: Quantifying the use of bioresources for promoting their sharing in scientific research. Gigascience 2013; 2: 7.
45. Filocamo M, Mazzotti R, Corsolini F et al: Cell Line and DNA Biobank from patients affected by genetic diseases. Open J Bioresources 2014; 1: e2.
46. Forsberg JS, Hansson MG, Evers K: International guidelines on biobank research leave researchers in ambiguity: why is this so? Eur J Epidemio 2013; 28: 449-451.
47. Wolf SM, Crock BN, Van Ness B et al: Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012; 14: 361-384.
48. Viberg J, Hansson MG, Langenskiöld S, Segerdahl P: Incidental findings: the time is not yet ripe for a policy for biobanks. Eur J Hum Genet 2014; 22: 437-441.
49. Mascalzoni D, Dove ES, Rubinstein Y et al: International Charter of principles for sharing bio-specimens and data. Eur J Hum Genet 2015; 23: 721-728.
50. Prainsack B, Buyx A: A solidarity-based approach to the governance of research biobanks. Med Law Rev 2013; 21: 71-91.
51. Thompson R, Johnston L, Taruscio D et al: RD-Connect: an integrated platform connecting databases, registries, biobanks and clinical bioinformatics for rare disease research. J Gen Intern Med 2014; 29(Suppl 3): S780-S787.